Literature DB >> 28131123

Update in the Management of Patients with Preeclampsia.

Nerlyne K Dhariwal1, Grant C Lynde2.   

Abstract

Hypertensive disorders of pregnancy complicate approximately 10% of all deliveries in the United States and are a leading cause of maternal and fetal morbidity and mortality. Preeclampsia is defined as hypertension in association with proteinuria, thrombocytopenia, impaired liver function, renal insufficiency, pulmonary edema, or new-onset cerebral or visual disturbances. The greatest risk factor for the development of preeclampsia is a history of preeclampsia. There currently is no effective means for the prevention of preeclampsia. Approximately 39% of patients diagnosed with preeclampsia have hypertension and approximately 20% have proteinuria 3 months postpartum. Preeclampsia increases the risk of patients developing hypertension later in life.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarkers; Hypertension; Magnesium sulfate; Preeclampsia; Renal dysfunction

Mesh:

Year:  2016        PMID: 28131123     DOI: 10.1016/j.anclin.2016.09.009

Source DB:  PubMed          Journal:  Anesthesiol Clin        ISSN: 1932-2275


  14 in total

1.  Human umbilical cord mesenchymal stem cell-derived exosome-mediated transfer of microRNA-133b boosts trophoblast cell proliferation, migration and invasion in preeclampsia by restricting SGK1.

Authors:  Dan Wang; Quan Na; Gui Yu Song; Leilei Wang
Journal:  Cell Cycle       Date:  2020-06-28       Impact factor: 4.534

2.  Multivariate logistic regression analysis of preeclampsia in patients with pregnancy induced hypertension and the risk predictive value of monitoring platelet, coagulation function and thyroid hormone in pregnant women.

Authors:  Li Zeng; Chunfang Liao
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

Review 3.  Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal.

Authors:  Gonçalo Miguel Peres; Melissa Mariana; Elisa Cairrão
Journal:  J Cardiovasc Dev Dis       Date:  2018-01-17

Review 4.  Maternal Morbidity and Mortality: Are We Getting to the "Heart" of the Matter?

Authors:  Jasmina Varagic; Patrice Desvigne-Nickens; Joyonna Gamble-George; Lisa Hollier; Christine Maric-Bilkan; Megan Mitchell; Victoria L Pemberton; Nicole Redmond
Journal:  J Womens Health (Larchmt)       Date:  2020-12-01       Impact factor: 2.681

5.  Increased LINC00922 in preeclampsia regulates the proliferation, invasion, and migration of placental trophoblast cells.

Authors:  Chengzhen Gao; Hui Yang; Fei Xia
Journal:  Ann Transl Med       Date:  2021-10

6.  Vitamin D stimulates miR-26b-5p to inhibit placental COX-2 expression in preeclampsia.

Authors:  Yang Cao; Xiaotong Jia; Yujia Huang; Jiao Wang; Chunmei Lu; Xiaolei Yuan; Jie Xu; Hui Zhu
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

7.  CTHRC1 promotes growth, migration and invasion of trophoblasts via reciprocal Wnt/β-catenin regulation.

Authors:  Yan Li; Bao-Xiang Xing; Yi-Hao Wang; Sha Yu; Han Zhao; Qing-Qing Lv; Cai-Xia Lu
Journal:  J Cell Commun Signal       Date:  2021-05-27       Impact factor: 5.782

8.  Extra-adrenal paraganglioma masquerading as severe preeclampsia.

Authors:  Hyeon Ji Kim; Shin Ho Yang; Sun Hye Yang; Seung Su Han; Gwang Jun Kim
Journal:  Obstet Gynecol Sci       Date:  2018-06-18

9.  Pharmacologic strategies to prevent hemodynamic changes after intubation in parturient women with hypertensive disorders of pregnancy: A systematic review and network meta-analysis protocol.

Authors:  Sang Won Yoon; Hyun Kang; Geun Joo Choi
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

Review 10.  Insight into the Key Points of Preeclampsia Pathophysiology: Uterine Artery Remodeling and the Role of MicroRNAs.

Authors:  Katarzyna Pankiewicz; Anna Fijałkowska; Tadeusz Issat; Tomasz M Maciejewski
Journal:  Int J Mol Sci       Date:  2021-03-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.